trial

COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark

NCTId NCT04775407
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Terminated
Enrollment 1,355 (actual)
Sponsored by Anders Fink-Jensen, MD, DMSci
Primary completion 2021-02-20
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
1,355 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2021-01-18
Primary completion
2021-02-20
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Blood sampling

Sponsors

Anders Fink-Jensen, MD, DMSciLead Sponsor

Sites

1 total
Copenhagen, Denmark

Facts & assertions

4 sourced
Enrollment
1,355
Phase
NA
Primary Completion Date
2021-02-20
Status
TERMINATED
relationships
The graph out of here
drug
Blood sampling
drug
lead_sponsor
Anders Fink-Jensen, MD, DMSci
company
indication
Severe Mental Disorder
indication
Covid19
indication
Mental Disorders
indication